“One Month to Save Lives”: Families race against 1st August deadline to secure access to life-saving rare disease drug

Contributed by: PA Media Assignments

Logo

PA Media Assignments logo

Images

PA Media Assignments associated0
PA Media Assignments associated1
PA Media Assignments associated2

Tags

NPUK
Xenpozyme

More Like This

Sanofi responds to NICE negative FAD of olipudase alfa

baby Aiyla,

A heartbreaking race against time: £600,000 needed to save 9-month-old UK baby Aiyla's life, Zolgensma is the only hope against SMA type 1.

Business Wire logo

Chiesi Global Rare Diseases Awards Research Grants to Advance Innovation in Lysosomal Diseases

Every baby in England to get life-saving genetic test from birth

Business Wire logo

Niagen Bioscience Receives Exclusive U.S. FDA Rare Pediatric Disease (RPD) Designation and European Medicines Agency Orphan Medicinal Product Designation (OMPD) for NB4168 for the Treatment of Ataxia Telangiectasia (A-T)

PR Newswire associated0

Chiesi Global Rare Diseases Launches New Research Grant Initiative to Support Research Excellence in Lysosomal Storage Disorders

Oxford-Harrington Rare Disease Centre Announces 2025 Scholars Advancing Promising Treatments

Azafaros Announces Initiation of two Global Phase 3 studies with Nizubaglustat in Niemann-Pick disease Type C (NPC) and GM1/GM2 gangliosidoses, respectively